Organizing pneumonia: A late phase complication of COVID-19 responding dramatically to corticosteroids
Organizing pneumonia emerges as a late phase complication of COVID-19. Corticosteroids are standard therapy for organizing pneumonia, but the question of whether an approach with high dose corticosteroids would be beneficial for patients with organizing pneumonia secondary to COVID-19 remains to be...
Main Authors: | Cilomar Martins de Oliveira Filho, Tarsila Vieceli, Caroline de Fraga Bassotto, João Pedro da Rosa Barbato, Tiago Severo Garcia, Rafael Selbach Scheffel |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Brazilian Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1413867021000040 |
Similar Items
-
Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumonia
by: Masato Tashiro, et al.
Published: (2017-12-01) -
Corticosteroids for all adult patients with community-acquired pneumonia?
by: Ger Rijkers, et al.
Published: (2015-01-01) -
The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis
by: Yue-Nan Ni, et al.
Published: (2019-03-01) -
Late-stage Use of Low-dose Corticosteroids Aid Recovery of Severe H1N1 Viral Pneumonia
by: Cao Bin, et al.
Published: (2013-09-01) -
Treatment of coccidioidomycosis-associated eosinophilic pneumonia with corticosteroids
by: Raz Y, et al.
Published: (2012-03-01)